BioCentury
ARTICLE | Clinical News

Beta-lactamase inhibitors regulatory update

January 2, 2001 8:00 AM UTC

Research Corp. Technologies (Tucson, Ariz.), which formed AlamX along with Southern Methodist University (Dallas, Texas), received U.S. Patent No. 6,156,745 covering penicillin derivatives that inhibi...